AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33974126 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 bouts of 4 s maximal cycling sprints with 45 s recovery
Number of subjects: 16
Study 34382932 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group receiving brief support for self-management of weight during child immunisation visits.
Number of subjects: 28
Study 34382932 — intervention group
Group type: COMPARATOR
Intervention: Usual-care group receiving a healthy lifestyle leaflet.
Number of subjects: 28
Study 32332423 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: Q‐tip touch test, speculum examination, then bimanual examination
Number of subjects: 200
Study 32332423 — intervention group
Group type: COMPARATOR
Intervention: Group B: Q‐tip touch test, bimanual examination, then speculum examination
Number of subjects: 200
Study 32332423 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A and Group B (combined)
Number of subjects: 200
Study 35948456 — intervention group
Group type: EXPERIMENTAL
Intervention: CEUS + 360°-TRUS
Number of subjects: 156
Study 35948456 — intervention group
Group type: COMPARATOR
Intervention: TRUS
Number of subjects: 156
Study 32747329 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified e-learning module
Number of subjects: 291
Study 32747329 — intervention group
Group type: COMPARATOR
Intervention: Control group (guidelines access before e-learning module)
Number of subjects: 291
Study 35025154 — intervention group
Group type: EXPERIMENTAL
Intervention: WANG Ju-yi's meridian diagnosis method combined with Bobath rehabilitation training
Number of subjects: 106
Study 35025154 — intervention group
Group type: COMPARATOR
Intervention: Bobath rehabilitation training alone
Number of subjects: 106
Study 32042081 — intervention group
Group type: EXPERIMENTAL
Intervention: CLL1-PM (prognostic model)
Number of subjects: 539
Study 32293830 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetris and therapy (EMDR)
Number of subjects: 40
Study 32293830 — intervention group
Group type: COMPARATOR
Intervention: Control group (therapy only - EMDR)
Number of subjects: 40
Study 35731497 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-compassion letter writing condition
Number of subjects: 53
Study 35731497 — intervention group
Group type: COMPARATOR
Intervention: Neutral writing control
Number of subjects: 53
Study 35731497 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher trait self-compassion
Number of subjects: 53
Study 34370275 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine tablets 3.5 mg/kg (CP3.5 group)
Number of subjects: 0
Study 34370275 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine tablets 3.5 mg/kg (CC7 group)
Number of subjects: 0
Study 32525946 — intervention group
Group type: EXPERIMENTAL
Intervention: Jumping exercises on a short-arm centrifuge at constant +1Gz
Number of subjects: 15
Study 32525946 — intervention group
Group type: EXPERIMENTAL
Intervention: Jumping exercises on a short-arm centrifuge at variable Gz (+0.5, +0.75, +1, +1.25, +1.5 Gz)
Number of subjects: 15
Study 32525946 — intervention group
Group type: COMPARATOR
Intervention: Vertical jumps (control intervention)
Number of subjects: 15
Study 35293087 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronedarone 400 mg twice daily
Number of subjects: 4628
Study 35293087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4628
Study 33795780 — intervention group
Group type: EXPERIMENTAL
Intervention: Repaired under tension (Group A, n=38)
Number of subjects: 90
Study 33795780 — intervention group
Group type: COMPARATOR
Intervention: Repaired without tension (Group B, n=52)
Number of subjects: 90
Study 33795780 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90
Study 36449490 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed reference range and sample size procedures for parallel-group studies
Number of subjects: 0
Study 36449490 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer programs for efficient calculation and exact analysis
Number of subjects: 0
Study 36449490 — intervention group
Group type: EXPERIMENTAL
Intervention: Real data example regarding tablet absorption rate and extent
Number of subjects: 0
Study 32926850 — intervention group
Group type: EXPERIMENTAL
Intervention: 15% dextrose injection (D15W)
Number of subjects: 50
Study 32926850 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline injection)
Number of subjects: 50
Study 32406581 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Facility Visit + Soapy Water Arm
Number of subjects: 404
Study 32406581 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Facility Visit + Handwashing Station Arm
Number of subjects: 404
Study 35803981 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian approach for modeling interaction of coffee genotypes with the environment
Number of subjects: 43
Study 35803981 — intervention group
Group type: EXPERIMENTAL
Intervention: Z21 genotype
Number of subjects: 43
Study 32895080 — intervention group
Group type: EXPERIMENTAL
Intervention: EAT‐26 scale
Number of subjects: 811
Study 32895080 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher EAT‐26 scores
Number of subjects: 811
Study 36125874 — intervention group
Group type: EXPERIMENTAL
Intervention: Group F (ferrule preparation)
Number of subjects: 20
Study 36125874 — intervention group
Group type: COMPARATOR
Intervention: Group B (butt joint porcelain margin)
Number of subjects: 20
Study 34814700 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior-lateral electrode position
Number of subjects: 468
Study 34814700 — intervention group
Group type: COMPARATOR
Intervention: Anterior-posterior electrode position
Number of subjects: 468
Study 33214480 — intervention group
Group type: EXPERIMENTAL
Intervention: Nissen fundoplication
Number of subjects: 107
Study 33214480 — intervention group
Group type: COMPARATOR
Intervention: Anterior 180-degree partial fundoplication
Number of subjects: 107
Study 33154023 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral supplementation with 16,000 IU of calcifediol per week
Number of subjects: 112
Study 33154023 — intervention group
Group type: COMPARATOR
Intervention: Placebo added to usual asthma treatment
Number of subjects: 112
Study 32043561 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational therapy (OT) behavioral intervention
Number of subjects: 101
Study 32043561 — intervention group
Group type: COMPARATOR
Intervention: Diabetes self-management education
Number of subjects: 101
Study 34342936 — intervention group
Group type: EXPERIMENTAL
Intervention: Stenting (10 subjects, 10% of total), along with medical management
Number of subjects: 110
Study 34342936 — intervention group
Group type: COMPARATOR
Intervention: Medical management only
Number of subjects: 110
Study 33038438 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical CPR (Jolfe AB/Stryker, Lund, Sweden)
Number of subjects: 127
Study 33038438 — intervention group
Group type: COMPARATOR
Intervention: Manual CPR
Number of subjects: 127
Study 34998991 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactometric detection of lung cancer using trained dogs (Bugs) in unblinded tests
Number of subjects: 216
Study 34998991 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactometric detection of lung cancer using trained dogs (Boolomo) in unblinded tests
Number of subjects: 216
Study 34998991 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactometric detection of lung cancer using trained dogs (Bugs) in single-blinded tests
Number of subjects: 216
Study 34998991 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactometric detection of lung cancer using trained dogs (Boolomo) in single-blinded tests
Number of subjects: 216
Study 34998991 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactometric detection of lung cancer using trained dogs (Bugs) in double-blinded studies
Number of subjects: 216
Study 34998991 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactometric detection of lung cancer using trained dogs (Boolomo) in double-blinded studies
Number of subjects: 216
Study 35807854 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g of whey protein microgel
Number of subjects: 0
Study 35807854 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg mulberry leaf extract with a complete 510 kcal meal
Number of subjects: 0
Study 32354736 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Number of subjects: 0
Study 33877019 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous urokinase
Number of subjects: 1002
Study 33877019 — intervention group
Group type: COMPARATOR
Intervention: Antiplatelet agents
Number of subjects: 1002
Study 33574437 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam intravenous sedation
Number of subjects: 20
Study 35959710 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified video-feedback intervention delivered in-home by trained mental health professionals over a period of 4-6 months.
Number of subjects: 30
Study 35959710 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control group)
Number of subjects: 30
Study 33856417 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiparametric Magnetic Resonance Imaging–Targeted Biopsy
Number of subjects: 0
Study 33856417 — intervention group
Group type: COMPARATOR
Intervention: Systematic Transrectal Ultrasonography Biopsy
Number of subjects: 0
Study 32527120 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Comics (MCs)
Number of subjects: 506
Study 36264198 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual child disease management programme for 8 weeks
Number of subjects: 80
Study 32959346 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe traumatic injury
Number of subjects: 8727
Study 32959346 — intervention group
Group type: EXPERIMENTAL
Intervention: Less severe traumatic injury
Number of subjects: 8727
Study 32959346 — intervention group
Group type: COMPARATOR
Intervention: No documented injury
Number of subjects: 8727
Study 32868588 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted blanket
Number of subjects: 16
Study 32868588 — intervention group
Group type: COMPARATOR
Intervention: Nonweighted blanket
Number of subjects: 16
Study 35171197 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous magnetic stimulation (TcMS) targeting the left stellate ganglion (n=14)
Number of subjects: 26
Study 35171197 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (n=12)
Number of subjects: 26
Study 33962125 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic measurement (BM) with calibration of 20 mm/mV and a sweep speed of 50 mm/s, enhancement 10×
Number of subjects: 153
Study 33962125 — intervention group
Group type: EXPERIMENTAL
Intervention: High precision measurement (HPM) with a sweep speed of 150 mm/s, enhancement 80-160×
Number of subjects: 153
Study 33962125 — intervention group
Group type: EXPERIMENTAL
Intervention: High precision measurement (HPM) in cases with P-DCS < 80 ms
Number of subjects: 153
Study 33962125 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic measurement (BM) and High precision measurement (HPM)
Number of subjects: 153
Study 32085836 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg S44819 twice a day
Number of subjects: 585
Study 32085836 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg S44819 twice a day
Number of subjects: 585
Study 32085836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 585
Study 32085836 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 585
Study 36174812 — intervention group
Group type: EXPERIMENTAL
Intervention: Ogawa® passive sampler with acid‐coated pads
Number of subjects: 40
Study 36174812 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposed acid‐coated pads without casing
Number of subjects: 40
Study 36174812 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid‐coated pads with protective casing
Number of subjects: 40
Study 36174812 — intervention group
Group type: COMPARATOR
Intervention: Standard boric acid solution
Number of subjects: 40
Study 32857445 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline directly observed therapy (DOT)
Number of subjects: 100
Study 32857445 — intervention group
Group type: COMPARATOR
Intervention: Varenicline self-administered therapy (SAT)
Number of subjects: 100
Study 35465733 — intervention group
Group type: COMPARATOR
Intervention: trastuzumab + chemotherapy (eribuline, capecitabine, or vinorelbine)
Number of subjects: 300
Study 35788754 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-based ultra-low-dose contrast medium (ULDCM)
Number of subjects: 150
Study 35788754 — intervention group
Group type: COMPARATOR
Intervention: Low-dose contrast medium (LDCM)
Number of subjects: 150
Study 35788754 — intervention group
Group type: COMPARATOR
Intervention: Ultra-low-dose contrast medium (ULDCM)
Number of subjects: 150
Study 34865332 — intervention group
Group type: EXPERIMENTAL
Intervention: Penetrating technique of scalp acupuncture + music education rehabilitation
Number of subjects: 60
Study 34865332 — intervention group
Group type: COMPARATOR
Intervention: Music education rehabilitation
Number of subjects: 60
Study 32212508 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint injection of Shuxuetong (SXT)
Number of subjects: 78
Study 32108724 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized volume (IND)
Number of subjects: 16
Study 32108724 — intervention group
Group type: COMPARATOR
Intervention: Standardized volume (N-IND)
Number of subjects: 16
Study 32372217 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 hour exercise session at 6:30 pm (E6:30)
Number of subjects: 16
Study 32372217 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 hour exercise session at 8:30 pm (E8:30)
Number of subjects: 16
Study 32372217 — intervention group
Group type: COMPARATOR
Intervention: Control session (CTL)
Number of subjects: 16
Study 35045869 — intervention group
Group type: EXPERIMENTAL
Intervention: Meclofenamate (MFA) combined with standard dose Temozolomide (TMZ)
Number of subjects: 42
Study 35045869 — intervention group
Group type: COMPARATOR
Intervention: Standard dose Temozolomide (TMZ)
Number of subjects: 42
Study 34661548 — intervention group
Group type: COMPARATOR
Intervention: Tablet PC
Number of subjects: 40
Study 34661548 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart Glasses
Number of subjects: 40
Study 34661548 — intervention group
Group type: COMPARATOR
Intervention: Tablet PC and Smart Glasses
Number of subjects: 40
Study 33367543 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher γ' fibrinogen levels
Number of subjects: 0
Study 33367543 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher total fibrinogen levels
Number of subjects: 0
Study 35387701 — intervention group
Group type: EXPERIMENTAL
Intervention: 3M 9320A+
Number of subjects: 1000
Study 35387701 — intervention group
Group type: COMPARATOR
Intervention: 3M 1870+
Number of subjects: 1000
Study 32703613 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 minutes of myofascial induction session
Number of subjects: 21
Study 32703613 — intervention group
Group type: COMPARATOR
Intervention: Placebo control group (unplugged pulsed 30 minutes of shortwave therapy)
Number of subjects: 21
Study 34952186 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibial fixation of the ACL graft at 0° (n = 85)
Number of subjects: 169
Study 34952186 — intervention group
Group type: COMPARATOR
Intervention: Tibial fixation of the ACL graft at 30° (n = 84)
Number of subjects: 169
Study 34952186 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibial fixation at 0°
Number of subjects: 169
Study 34952186 — intervention group
Group type: COMPARATOR
Intervention: Tibial fixation at 30°
Number of subjects: 169
Study 34952186 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (0° and 30°)
Number of subjects: 169
Study 34377158 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab + Bevacizumab + Gemcitabine/Cisplatin (Gem/Cis)
Number of subjects: 150
Study 34377158 — intervention group
Group type: COMPARATOR
Intervention: Atezolizumab + Placebo + Gemcitabine/Cisplatin (Gem/Cis)
Number of subjects: 150
Study 35909582 — intervention group
Group type: EXPERIMENTAL
Intervention: Ornidazole mixture‐assisted filling
Number of subjects: 124
Study 35909582 — intervention group
Group type: COMPARATOR
Intervention: Pulp mummification filling
Number of subjects: 124
Study 32730628 — intervention group
Group type: EXPERIMENTAL
Intervention: iv acetaminophen
Number of subjects: 195
Study 32730628 — intervention group
Group type: COMPARATOR
Intervention: iv fentanyl
Number of subjects: 195
Study 33020078 — intervention group
Group type: EXPERIMENTAL
Intervention: PartnerCARE online intervention
Number of subjects: 60
Study 33020078 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 60
Study 35371287 — intervention group
Group type: EXPERIMENTAL
Intervention: CNHM model during bladder perfusion treatment
Number of subjects: 60
Study 35371287 — intervention group
Group type: COMPARATOR
Intervention: Ordinary health monitoring mode
Number of subjects: 60
Study 33112779 — intervention group
Group type: EXPERIMENTAL
Intervention: Handshake stewardship (HS‐ASP)
Number of subjects: 162
Study 32380271 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab (5 mg/kg) administered at weeks 0, 2, and 6
Number of subjects: 60
Study 32380271 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline control) administered at weeks 0, 2, and 6
Number of subjects: 60
Study 35786572 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular overdentures retained by one implant
Number of subjects: 47
Study 35786572 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular overdentures retained by two implants
Number of subjects: 47
Study 35786572 — intervention group
Group type: EXPERIMENTAL
Intervention: Expected burdens
Number of subjects: 47
Study 35786572 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 47
Study 34411219 — intervention group
Group type: EXPERIMENTAL
Intervention: Oversized drilling (OD) group
Number of subjects: 20
Study 34411219 — intervention group
Group type: COMPARATOR
Intervention: Manufacturer-recommended (MR) group
Number of subjects: 20
Study 32456468 — intervention group
Group type: EXPERIMENTAL
Intervention: m-health intervention targeting physical activity and sleep
Number of subjects: 160
Study 32713644 — intervention group
Group type: EXPERIMENTAL
Intervention: Left coronary artery geometry parameters
Number of subjects: 121
Study 32713644 — intervention group
Group type: EXPERIMENTAL
Intervention: First centimeter angle and minimal angle in 3D
Number of subjects: 121
Study 32916128 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab 1 mg/kg plus Ipilimumab 3 mg/kg
Number of subjects: 90
Study 35443623 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance care planning (ACP) intervention delivered by trained nurses, including two ACP conversations and an information brochure.
Number of subjects: 27
Study 35443623 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational programme and topic guides for nurses.
Number of subjects: 27
Study 35443623 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses as ACP facilitators in home care.
Number of subjects: 27
Study 35443623 — intervention group
Group type: EXPERIMENTAL
Intervention: Contextual factors influencing ACP engagement.
Number of subjects: 27
Study 32496547 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized splint ligation with a cleavable adapter
Number of subjects: 0
Study 36084202 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fluence Q-switched (LFQS) Nd: YAG 1064-nm laser
Number of subjects: 20
Study 36084202 — intervention group
Group type: COMPARATOR
Intervention: Conventional high fluence Q-switched (HFQS) Alexandrite 755-nm laser
Number of subjects: 20
Study 33334240 — intervention group
Group type: EXPERIMENTAL
Intervention: Relatively Easy Success (RES) criteria
Number of subjects: 30
Study 33334240 — intervention group
Group type: COMPARATOR
Intervention: Difficult Success (DS) criteria
Number of subjects: 30
Study 36181104 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with donepezil hydrochloride orally
Number of subjects: 0
Study 36181104 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture combined with donepezil hydrochloride orally
Number of subjects: 0
Study 33640715 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow-band imaging (NBI) with enhanced attention (EA)
Number of subjects: 1000
Study 33640715 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow-band imaging (NBI) with standard attention (SA)
Number of subjects: 1000
Study 33640715 — intervention group
Group type: COMPARATOR
Intervention: White light endoscopy (WLE) with standard attention (SA)
Number of subjects: 1000
Study 33640715 — intervention group
Group type: COMPARATOR
Intervention: White light endoscopy (WLE) with enhanced attention (EA)
Number of subjects: 1000
Study 33640715 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedation
Number of subjects: 1000
Study 32481442 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypothermia
Number of subjects: 34
Study 32481442 — intervention group
Group type: COMPARATOR
Intervention: Non-mild hypothermia
Number of subjects: 34
Study 36173649 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral octreotide capsules (OOC) at 60 mg/d, with option to titrate to 40 or 80 mg/d
Number of subjects: 40
Study 34591812 — intervention group
Group type: EXPERIMENTAL
Intervention: High preprocedural anxiety (defined as a score > 40)
Number of subjects: 205
Study 33050758 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum voluntary molar bite force (MVMBF)
Number of subjects: 100
Study 35840876 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral paravertebral block (PVB) with 20 mL of ropivacaine 0.375% before incision
Number of subjects: 60
Study 35840876 — intervention group
Group type: COMPARATOR
Intervention: No block (Control group)
Number of subjects: 60
Study 33336564 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary K wire fixation (IMNK)
Number of subjects: 43
Study 33336564 — intervention group
Group type: COMPARATOR
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 43
Study 33336564 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IMNK and ORIF)
Number of subjects: 43
Study 32205111 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guided percutaneous puncture and closure with additional hands-on training on a pulsatile flow model
Number of subjects: 14
Study 32205111 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound guided percutaneous puncture and closure without additional hands-on training
Number of subjects: 14
Study 32205111 — intervention group
Group type: EXPERIMENTAL
Intervention: Experienced participants (more than 20 punctures performed before the study)
Number of subjects: 14